FDA Import Refusal 8NP-0144593-5/10002/1 — Hybio Pharmaceutical (Wuhan) Co., Ltd.
The FDA refused shipment 8NP-0144593-5/10002/1 from Hybio Pharmaceutical (Wuhan) Co., Ltd. (China) on May 14, 2026. The refused product falls under Drugs and Biologics — SEMAGLUTIDE (ANTI-DIABETIC). Cited charges: 118,2280,3280
Refusal Details
- Date
- May 14, 2026
- Country
- China
- Product Category
- Drugs and Biologics
- Product Code
- 61PCT72 SEMAGLUTIDE (ANTI-DIABETIC)
- Charges
- 118,2280,3280